Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Apoptosis Assays Market Research Report: Information By Product (Kits, Reagents, and instruments), By Technique (Flow Cytometry, Fluorescence Microscopy, Spectrophotometer, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

ID: MRFR/LS/5335-HCR | 100 Pages | Author: Rahul Gotadki| May 2024

Global Apoptosis Assays Market Overview

Apoptosis Assays Market Size valued at USD 1.4 Billion in 2022. The Apoptosis Assays market industry is projected to grow from USD 1.53 Billion in 2023 to USD 3.24 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.80% during the forecast period (2023 - 2032). Increased emersion of novel radionuclide tracers and increase in innovative assay kits, and increased investment in R&D activities are the prime market drivers enhancing the growth of market. 

Apoptosis Assays Market Overview

Source: The Secondary Research, Primary Research, MRFR Database and Analyst Review

Apoptosis Assays Market Trends

  • Growing advent of new radionuclide tracers is driving the market growth.

Market CAGR for apoptosis assays is being driven by the rising advent of new radionuclide tracers like caspase inhibitors and radiolabeled annexin V, which has improved the efficiency of the real-time monitoring of cellular death. The ongoing research into apoptosis-modulating medications is another factor anticipated to boost the apoptosis assay market globally. The growing demand for high-content clinical research and diagnostics, mainly for cancer, is fueling the market growth. Infectious diseases like autoimmune diseases, cancer and others are increasing.

The apoptosis assays help in giving in-depth insights into the cell death mechanisms, biological drugs and small molecules and the function of the immune system at the molecular level. Controlling and understanding the mechanism included in several steps of apoptosis helps in new drug innovations. The rising demand for caspase activity assays with the Bcl-2 protein family throughout the pharmaceutical companies for cell death detection has fueled the growth of the market. The immense research is carried out is expected to offer significant momentum to the market penetration of these assays, according to the director of Manufacturers of America and pharmaceutical research. The growing application of assay products will be further expected to be beneficial for different pharmaceutical companies. The key market players are implementing the important fact that the multiple points of confirmation of apoptosis help in epidemiological studies, and therefore, the solutions and product lines are offered depending on different principles.

The programmed cell death mechanism had an important role in the start and progression of different chronic conditions. The broad adoption of clinical cytoprotective and cytotoxic agents in order to treat ischemic diseases, neurodegenerative diseases, and cancer represents one of the leading reasons for the growing demand for apoptosis assays for discovering new drugs. The live-cell and real-time assays are attaining traction with multiple other methods in order to monitor apoptotic events over a period of time. Thus, driving the Apoptosis Assays market revenue.

However, the less availability of skilled personnel for the research and development of apoptosis assays. Cells can undergo apoptosis because the cells that die due to the severe injury typically swell and burst and experience necrosis, thus becoming the factor for obstruction in the market growth.

Apoptosis Assays Market Segment Insights

Apoptosis Assays Product Insights

The Apoptosis Assays market segmentation, based on product, includes Kits, Reagents, and Instruments. The kits segment dominated the market, accounting for the largest market revenue and is expected to remain the same throughout the forecast period. A substantial growth in the adoption of apoptosis assays throughout drug design fabrication and manufacturing is anticipated to provide opportunities for product manufacturers. The investment by the key market players in the development of an affordable and innovative assay kits, with a growing preference for apoptosis assay kits among users, is anticipated to fuel the dominance of the segment. Further, the reagents form an integral part of the apoptosis assay protocols, and therefore it is the fastest-growing segment throughout the forecast period.

Figure 1: Apoptosis Assays Market, by Product, 2022 & 2032 (USD Billion) 

Apoptosis Assays Market, by Product, 2022 & 2032

Source: The Secondary Research, Primary Research, MRFR Database and Analyst Review

Apoptosis Assays Technique Insights

The Apoptosis Assays market segmentation, based on technique, includes Flow Cytometry, Fluorescence Microscopy, Spectrophotometer, and Others. The flow cytometry segment dominates the market due to the inclination of researchers toward adopting flow cytometry-based mitochondrial assays. Flow cytometry assists in making a clear distinction between intact mitochondria and permeabilized mitochondria. Flow cytometry is anticipated to dominate the market globally during the forecast period because it is considered to be a premium standard detection method. Further, the fluorescent microscopy segment is expected to witness the fastest growth.

Apoptosis Assays Regional Insights

By region, the study gives market insights into the North America, Europe, Asia-Pacific and the Rest of the World. The North American Apoptosis Assays market area dominates the market due to the presence of major market players, the prevalence of chronic diseases like cancer and the availability of the advanced healthcare infrastructure in this region. Further, the US is the largest contributor to the growth of the market owing to the developments related to apoptosis-modulating drugs in the country and the rising geriatric population.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil.



Source: The Secondary Research, Primary Research, MRFR Database and Analyst Review

The Asia-Pacific Apoptosis Assays Market accounts for the second-largest market share due to the growing prevalence of chronic and infectious diseases, large patient population, rising healthcare expenditure, and growing interest of key market players in this region. Moreover, China’s Apoptosis Assays market held the largest market share, and the Indian Apoptosis Assays market was the rapid-growing market in Asia-Pacific region.

Europe's Apoptosis Assays market is expected to grow at the rapid CAGR from 2023 to 2032. This is due to the rising prevalence of chronic diseases and growing investment in recent technology. Further, the German Apoptosis Assays market held the largest market share, and the UK Apoptosis Assays market was the rapid-growing market in the European region.

Apoptosis Assays Key Market Players & Competitive Insights

Leading market players are investing hugely in research and development in order to expand their product lines, which will help the Apoptosis Assays market grow even more. Market players are also undertaking a variety of strategic activities to spread their footprint, with important market developments inclusive of new product launches, contractual agreements, higher investments, mergers and acquisitions, and collaboration with other organizations. To spread and survive in a more competitive and rising market climate, the Apoptosis Assays industry must offer cost-effective items.

Manufacturing locally to reduce the operational costs is one of the key business tactics utilized by the manufacturers in the Apoptosis Assays industry to benefit the clients and increase the market sector. In recent years, the Apoptosis Assays industry has offered some of the most significant advantages to the medicine. Major players in the Apoptosis Assays market, including GE Healthcare, Merck & Co Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Geno Technology, GeneCopoeia Inc., Promega Corporation, and others, are trying to increase market demand by investing in the research and development operations.

GE Healthcare Technologies Inc, headquartered in Chicago, Illinois, the US, is an American medical device supplier which fabricates, develops, manufactures and sells diagnostic imaging and clinical imaging systems; services and products for drug delivery, cellular technologies, biopharmaceutical manufacturing and range of healthcare IT solutions. The company also offers services like performance solutions services and performance enhancements, computerized data management and remote diagnostic and repair services of the medical equipment produced by the company and others. The company conducts its operations throughout the globe via affiliates and subsidiaries. In 2018, GE Healthcare Life Sciences inaugurated a novel production facility in Pasching, Austria. The newly opened manufacturing site will assist in strengthening the product supply for biopharmaceutical companies in Europe.

Merck & Co Inc, headquartered in New Jersey, the US, is a biopharmaceutical company that emphasizes on invention, development, production and marketing of prescription medicines, vaccines, biologic therapies, and animal health products. It provides prescription products for therapy areas related to cancer, cardiovascular, immune disorders, respiratory, diabetes and infection. The company offers animal health products like poultry products, vaccines, livestock products and aquaculture products. The company supplies medicines to drugs, retailers, wholesalers, hospitals, and government agencies. In 2015, the company acquired Sigma Aldrich Corporation, a supplier in the research and the fine chemicals market, providing organic and inorganic chemicals, reagents and many more. This acquisition strengthened the life science segment of Merck. SAFC Commercial business of Sigma-Aldrich is now a part of the life science segment of Merck.

Key Companies in the Apoptosis Assays market includes

  • GE Healthcare

  • Merck & Co Inc.

  • Becton, Dickinson and Company

  • Bio-Rad Laboratories

  • Thermo Fisher Scientific

  • Danaher Corporation

  • Sartorius AG

  • Geno Technology

  • GeneCopoeia Inc.

  • Promega Corporation

Apoptosis Assays Industry Developments

March 2022:KaraMD announced the Pure Health Apple Cider Vinegar Gummies, a vegan gummy emphasized to assist ketosis, digestion regulation, weight management, and encourage greater levels of energy.

January 2022:Solace Nutrition, the US-based medical nutrition company, bought the R-Kane Nutritionals' assets for an unknown sum. This asset acquisition enables Solace Nutrition in order to develop synergy between both brands, accelerate the growth, and to establish a position in an adjacent nutrition sector. The R-Kane Nutritionals is a firm established in the US that specializes in high-protein meal replacement products for weight loss.

February 2021:Hydroxycut's new creation, CUT Energy, a delectable clean energy drink, was intoduced. This powerful mix was carefully formulated for the regular energy drink consumers, the exercise enthusiasts, and dieters looking to lose weight.

Apoptosis Assays Market Segmentation

Apoptosis Assays Product Outlook

  • Kits

  • Reagents

  • Instruments

Apoptosis Assays Technique Outlook

  • Flow Cytometry

  • Fluorescence Microscopy

  • Spectrophotometer

  • Others

Apoptosis Assays Regional Outlook

  • North America

  • US

  • Canada

  • Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Attribute/Metric Details
Market Size 2022 USD 1.4 Billion
Market Size 2023 USD 1.53 Billion
Market Size 2032 USD 3.24 Billion
Compound Annual Growth Rate (CAGR) 9.80% (2023-2032)
Base Year 2022
Market Forecast Period 2023-2032
Historical Data 2018- 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, The Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Product, Technique and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The US, Canada, German, France, UK, Italy, Spain, Japan, India, China, Australia, South Korea, and Brazil
Key Companies Profiled  GE Healthcare, Merck & Co Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Geno Technology, GeneCopoeia Inc., Promega Corporation  
Key Market Opportunities Increasing adoption of apoptosis assays.
Key Market Dynamics Increased emersion of novel radionuclide tracers and innovative assay kits.

Frequently Asked Questions (FAQ) :

The Apoptosis Assays market size valued at USD 1.4 Billion in 2022.

The market is foreseen to rise at a CAGR of 9.80% during the forecast period, 2023-2032.

North America had the largest share of the market

The key players in market are GE Healthcare, Merck & Co Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Geno Technology, GeneCopoeia Inc., and Promega Corporation.

The kits category dominated the market in the year 2022.

The Flow Cytometry had the largest share in the market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.